An observational study in Acne, Acne Vulgaris and Acne Keloidalis, sponsored by ProgenaBiome. Withdrawn at 1 site in United States. Per ClinicalTrials.gov, last updated 2025-06-05.
Sponsored by ProgenaBiome · Observational
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
The goal of this Research Study is to better understand how the genetic information in subject's microbiome correlates to acne.
790 studies on the registry are indexed under Acne Vulgaris; 93 are open to participants now.
Browse Acne Vulgaris studies →ProgenaBiome is the lead sponsor of 47 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with acne
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Signed , demonstrating that the patient understands the procedures required for the study and the purpose of the study
a. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who have been diagnosed with acne, subdivided into the various types.
Other: No intervention
There is no intervention for this study.
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized with acne.
Time frame: Three years
Plan to share: No — There is no plan to share IPD
No publications or documents are linked to this record.
Started Mar 2020 (actual). Primary completion is estimated for Mar 2030, 120 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ProgenaBiome